Yttrium-90 radioembolization versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparative analysis
Marco Massani(AULSS 2 Marca Trevigiana), N. Bassi(Ca' Foncello Hospital), Cesare Ruffolo(Ca' Foncello Hospital), P. Maccatrozzo(Ca' Foncello Hospital), Davide Barbisan(Ca' Foncello Hospital), F. Pozza(Ca' Foncello Hospital), Giovanni Pirozzolo(Ottawa Hospital)
Cited by 0
Related Papers
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
|Journal of Hepatology|2018|191
Platelet-Derived Growth Factor-D And Rho Gtpases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcinoma
|Hepatology|2013|170
Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy
|Annals of Surgical Oncology|2015|124
<scp>TACE</scp> versus <scp>TARE</scp> for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
|Cancer Medicine|2022|93
Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome
|Clinical Cancer Research|2016|91